Open AccessAn advanced non-small cell lung cancer patient with EGFR and KRAS mutations, and PD-L1 positive, benefited from immunotherapy: a case report
Author(s) -
Ronghua Yang,
Dong Wang,
Xia Li,
Kaiping Mao,
Jinglong Wang,
Peng Li,
Xiaoliang Shi,
Shanshan Zhang,
Yongjie Wang
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-403
Subject(s) - pemetrexed , medicine , kras , bevacizumab , lung cancer , immunotherapy , oncology , gefitinib , chemotherapy , targeted therapy , cancer research , epidermal growth factor receptor , cancer , colorectal cancer , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom